Back to search results

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Abroad (travel likely)RecruitingPHASE2

Conditions

Wilms Tumor · Rhabdoid Tumor · Malignant Peripheral Nerve Sheath Tumors · MPNST · Nephroblastoma · XPO1 Gene Mutation · Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Children's Hospital of Los Angeles (Data Collection Only), Los Angeles, California, United States

    Contact: Study coordinator (Rachana Shah, MD) · 323-660-2450

  • Stanford Medicine Children's Health (Data Collection Only), Palo Alto, California, United States

    Contact: Study coordinator (Chelsey Burke, MD) · 650-497-8953

  • Children's National Hospital (Data Collection Only), Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Aerang Kim, MD) · 888-884-2327

  • Children's Healthcare of Atlanta (Data Collection and Specimen Analysis), Atlanta, Georgia, United States

    Contact: Study coordinator (Thomas Cash, MD) · 404-785-0910

  • Ann & Robert H. Lurie Children'S Hospital of Chicag, Chicago, Illinois, United States

    Contact: Study coordinator (Elizabeth Sokol, MD) · 800-543-7362

  • Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts, United States

    Contact: Study coordinator (Elizabeth Mullen, MD) · 617-632-1938

  • Washington University, St Louis, Missouri, United States

    Contact: Study coordinator (Amy Armstrong, MD) · 314-454-6018

  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Michael Ortiz, MD) · 833-675-5437

  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Michael Ortiz, MD) · 833-675-5437

  • Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Michael Ortiz, MD) · 833-675-5437

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack, New York, United States

    Contact: Study coordinator (Michael Ortiz, MD) · 833-675-5437

  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Michael Ortiz, MD) · 833-675-5437

  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York, New York, United States

    Contact: Study coordinator (Michael Ortiz, MD) · 833-675-5437

  • Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, United States

    Contact: Study coordinator (Michael Ortiz, MD) · 833-675-5437

  • Cincinnati Children's Hospital Medical Center (Data collection only), Cincinnati, Ohio, United States

    Contact: Study coordinator (Brian Turpin, DO) · 513-636-3200

  • Cook Children's Health Care System (Data Collection Only), Fort Worth, Texas, United States

    Contact: Study coordinator (Kelly Vallance, MD, MPH) · 682-885-4007
Study leads

  • Michael Ortiz, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)